Dietmar Berger
2018
In 2018, Dietmar Berger earned a total compensation of $5M as Former Global Head of Research & Development at Atara Biotherapeutics.
Compensation breakdown
| Bonus | $427,767 |
|---|---|
| Option Awards | $2,121,337 |
| Salary | $320,385 |
| Stock Awards | $2,102,500 |
| Other | $451 |
| Total | $4,972,439 |
Berger received $2.1M in option awards, accounting for 43% of the total pay in 2018.
Berger also received $427.8K in bonus, $320.4K in salary, $2.1M in stock awards and $451 in other compensation.
Rankings
In 2018, Dietmar Berger's compensation ranked 2,031st out of 14,244 executives tracked by ExecPay. In other words, Berger earned more than 85.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,031 out of 14,244 | 86th |
Division Manufacturing | 729 out of 5,765 | 87th |
Major group Chemicals And Allied Products | 241 out of 2,128 | 89th |
Industry group Drugs | 192 out of 1,817 | 89th |
Industry Biological Products, Except Diagnostic Substances | 40 out of 339 | 88th |
Source: SEC filing on April 22, 2020.
Berger's colleagues
We found four more compensation records of executives who worked with Dietmar Berger at Atara Biotherapeutics in 2018.